Premier Biomedical Inc Asset Turnover Ratio (BIEI), as of fourth quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Premier Biomedical Inc  (BIEI)
 

Premier Biomedical Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Premier Biomedical Inc's asset turnover ratio, the ratio that measures the ability of Premier Biomedical Inc's assets to generate revenue, sequentially decreased to 0.1 in the fourth quarter (Dec 31 2019), which does not come as a surprise, as the Premier Biomedical Inc continue to experience difficult business climate.

Within sector 42 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2019 compared to the preceding quarter from 2682 to 3822.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BIEI Asset Turnover Ratio (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Asset Change -38.81 % -18.69 % -11.65 % -22.1 % -21.09 %
Y / Y Revenue Change -85.63 % -57.87 % -68.78 % -44.82 % -41.32 %
Asset Turnover Ratio (TTM) 0.1 0.13 0.15 0.19 0.21
BIEI's Total Ranking # 3822 # 2682 # 2754 # 3813 # 3812
Seq. Asset Change -45.57 % 19.41 % 0.28 % -6.11 % -27.68 %
Seq. Revenue Change -62.31 % -8.19 % -34.21 % -36.87 % 10.47 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 513
Overall Market # 3822

Asset Turnover Ratio Statistics
High Average Low
0.31 0.19 0.1
(Jun 30 2018)   (Dec 31 2019)




BIEI Company Profile • Back to BIEI Efficiency Comparisons • Compare BIEI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Assets at quarter ending Dec 31 2019
Bionano Genomics Inc   0.39 $ 10.130  Millions$ 26.044  Millions
Health right Discoveries Inc   0.39 $ 3.468  Millions$ 8.925  Millions
Avanos Medical Inc   0.39 $ 697.600  Millions$ 1,806.175  Millions
Amgen Inc   0.39 $ 23,362.000  Millions$ 60,653.000  Millions
Ionis Pharmaceuticals Inc   0.38 $ 1,122.599  Millions$ 2,960.439  Millions
Biomarin Pharmaceutical Inc  0.38 $ 1,704.048  Millions$ 4,519.237  Millions
Bristol myers Squibb Company  0.38 $ 26,145.000  Millions$ 69,343.500  Millions
Rigel Pharmaceuticals Inc  0.37 $ 59.288  Millions$ 158.143  Millions
Gw Pharmaceuticals Plc  0.37 $ 311.332  Millions$ 830.609  Millions
Amneal Pharmaceuticals Inc   0.37 $ 1,500.211  Millions$ 4,004.140  Millions
Sol gel Technologies Ltd   0.37 $ 22.904  Millions$ 61.301  Millions
United Therapeutics Corporation  0.37 $ 1,448.800  Millions$ 3,884.650  Millions
Biocryst Pharmaceuticals Inc   0.37 $ 48.835  Millions$ 131.116  Millions
American Shared Hospital Services  0.37 $ 20.605  Millions$ 55.366  Millions
Surgery Partners Inc   0.37 $ 1,831.400  Millions$ 4,927.050  Millions
Opko Health Inc   0.37 $ 901.935  Millions$ 2,427.580  Millions
Capforce Inc   0.37 $ 3.499  Millions$ 9.469  Millions
Anika Therapeutics Inc   0.37 $ 114.610  Millions$ 311.078  Millions
Mylan N v   0.37 $ 11,500.500  Millions$ 31,508.125  Millions
Inspiremd Inc   0.36 $ 3.721  Millions$ 10.211  Millions
Beyond Air Inc   0.36 $ 3.927  Millions$ 10.780  Millions
Gilead Sciences Inc   0.36 $ 22,449.000  Millions$ 61,705.000  Millions
Emmaus Life Sciences Inc   0.36 $ 22.752  Millions$ 62.901  Millions
Supernus Pharmaceuticals inc   0.36 $ 392.755  Millions$ 1,089.079  Millions
Ac Immune Sa  0.36 $ 111.167  Millions$ 309.238  Millions
Palvella Therapeutics Inc   0.36 $ 46.279  Millions$ 129.934  Millions
BIOFORCE NANOSCIENCES HOLDINGS, INC.  0.36 $ 0.018  Millions$ 0.050  Millions
Athenex Inc   0.36 $ 101.229  Millions$ 285.027  Millions
Intercept Pharmaceuticals inc   0.35 $ 252.002  Millions$ 712.052  Millions
Teladoc Health Inc   0.35 $ 553.307  Millions$ 1,572.056  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.